Published in Carcinogenesis on July 01, 1999
Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci U S A (2008) 2.47
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc Natl Acad Sci U S A (2008) 1.65
Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer (2004) 1.63
Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ). PLoS One (2011) 1.23
Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol (2001) 1.17
Isolation and characterization of an immortalized mouse urogenital sinus mesenchyme cell line. Prostate (2006) 1.14
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol (2013) 1.07
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Mol Med (2012) 1.06
Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice. PLoS One (2012) 1.01
Myofibroblasts: paracrine cells important in health and disease. Trans Am Clin Climatol Assoc (2000) 0.97
Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells. PLoS One (2011) 0.92
Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation. Int J Biol Sci (2014) 0.91
The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian J Androl (2008) 0.90
Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription. Prostate (2014) 0.89
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S). Mol Cancer Ther (2011) 0.89
Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling. Nucleic Acids Res (2010) 0.85
Automated tracking of tumor-stroma morphology in microtissues identifies functional targets within the tumor microenvironment for therapeutic intervention. Oncotarget (2015) 0.84
Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH). Mol Endocrinol (2013) 0.83
In vitro and in vivo model systems used in prostate cancer research. J Biol Methods (2015) 0.81
Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment. J Cell Biochem (2014) 0.80
Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. Oncotarget (2016) 0.80
The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition. PLoS One (2014) 0.79
Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions. Differentiation (2008) 0.79
Establishment of an invasive prostate cancer model in transgenic rats by intermittent testosterone administration. J Toxicol Pathol (2014) 0.78
TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures. Oncotarget (2015) 0.76
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep (2016) 0.75
Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer. Lab Invest (2015) 0.75
Stromal Androgen Receptor in Prostate Cancer Development and Progression. Cancers (Basel) (2017) 0.75
Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90. Cancers (Basel) (2016) 0.75
The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. Prostate (2017) 0.75
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med (1994) 8.97
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature (1983) 4.34
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis (1997) 2.97
Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell (1990) 2.95
A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol (1994) 2.87
Retained asymptomatic third molars and risk for second molar pathology. J Dent Res (2013) 2.43
Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science (1992) 2.40
Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest (1994) 2.29
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol (2001) 2.25
Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science (1985) 2.23
Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature (1990) 2.23
Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med (2000) 2.21
Hematologic effects of flt3 ligand in vivo in mice. Blood (1996) 2.02
Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate (1999) 2.02
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature (1984) 1.99
Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc (1984) 1.89
A test of crystal structure prediction of small organic molecules. Acta Crystallogr B (2000) 1.84
Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol (1996) 1.82
The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor. Mol Cell Biol (1991) 1.76
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74
Medical and economic costs of psychologic distress in patients with coronary artery disease. Mayo Clin Proc (1995) 1.70
Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature (1991) 1.67
Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (1991) 1.66
Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab (1975) 1.64
Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J (1991) 1.58
Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci (1994) 1.55
Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med (1993) 1.52
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51
c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell (1992) 1.50
Long-term psychologic implications of congenital heart disease: a 25-year follow-up. Mayo Clin Proc (1991) 1.49
Fish models for environmental carcinogenesis: the rainbow trout. Environ Health Perspect (1996) 1.48
Chemical and biological evidence links microcystins to salmon 'netpen liver disease'. Toxicon (1993) 1.46
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer (1992) 1.45
A prospective psychological evaluation of patients with dysphagia of various etiologies. Dysphagia (1996) 1.44
Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci U S A (1985) 1.43
Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg (1984) 1.41
Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40
Transformation of human cells in culture by N-methyl-N'-nitro-N-nitrosoguanidine. Nature (1975) 1.39
Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood (1994) 1.37
Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J (1991) 1.37
Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood (1991) 1.35
Pulmonary function studies in healthy Pakistani adults. Thorax (1978) 1.34
The role of the otu gene in Drosophila oogenesis. Bioessays (1988) 1.34
Echocardiographic detection of large left to right shunts and cardiomyopathies in infants and children. Am J Cardiol (1976) 1.34
Self-injurious behavior: a state-wide prevalence survey of the extent and circumstances. Appl Res Ment Retard (1986) 1.34
Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol (1991) 1.32
The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med (1991) 1.32
Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology (1989) 1.32
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Perspect (2001) 1.31
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine. J Biol Chem (2001) 1.27
The production of myeloid blood cells and their regulation during health and disease. Crit Rev Oncol Hematol (1988) 1.26
Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg (1981) 1.25
Biological characteristics and viral susceptibility of an African green monkey kidney cell line (Vero). Proc Soc Exp Biol Med (1969) 1.25
A device for recording automatic audio tape recording. J Appl Behav Anal (1971) 1.24
Bactericidal properties of a new water disinfectant. Appl Environ Microbiol (1985) 1.23
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Utilizing increased response effort to reduce chronic hand mouthing. J Appl Behav Anal (1998) 1.22
Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate (2001) 1.21
Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci (1993) 1.21
Syntheses and antibacterial activity of new N-halamine compounds. J Pharm Sci (1987) 1.20
Macrophages express a plasma membrane receptor for basement membrane laminin. Am J Pathol (1986) 1.19
Developmental abnormalities in Steel17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes Dev (1992) 1.19
Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis (2007) 1.19
Inherited susceptibility to retrovirus-induced transformation of Gardner syndrome cells. Am J Hum Genet (1983) 1.17
Cytopathic and plaque assay of rubella virus in a line of African green monkey kiency cells (Vero). Proc Soc Exp Biol Med (1967) 1.16
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene (1998) 1.15
Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest (1987) 1.14
Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem (2002) 1.13
Clinical evaluation of the self-injurious behavior inhibiting system (SIBIS). J Appl Behav Anal (1990) 1.13
Mycobacterium avium-intracellulare complex: evaluation with CT. Radiology (1993) 1.13
Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J Clin Endocrinol Metab (1976) 1.12
Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc (1983) 1.12
Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Differ (1991) 1.12
Characterization of human cells transformed in vitro by N-methyl-N'-nitro-N-nitrosoguanidine. Int J Cancer (1977) 1.12
Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero). Proc Soc Exp Biol Med (1967) 1.11
Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis (1998) 1.11
Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res (1997) 1.10
Sleep disturbances in patients with mild-stage Alzheimer's disease. J Gerontol (1990) 1.10
Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas. Cancer Res (1989) 1.10
Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res (2001) 1.10
Inactivation of Legionella pneumophila by hypochlorite and an organic chloramine. Appl Environ Microbiol (1987) 1.09
Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol (1991) 1.08
The influence of age on the electroretinogram and visual evoked potential. Doc Ophthalmol (1985) 1.08
Cycloheximide-dependent reversion of human cells transformed by MSV and chemical carcinogen. Science (1979) 1.07
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 1.07
Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc Natl Acad Sci U S A (1991) 1.07
Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens. Science (1986) 1.07
Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans. Toxicol Appl Pharmacol (2000) 1.06
Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis (1996) 1.06
Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. Oncogene Res (1988) 1.06